Matthew B. Murphy, General Counsel at Nautilus Biotechnology ($NAUT), made one open market purchase of shares in the last year, totaling $12,858. His most recent buy occurred on September 4, 2025. This ranks 4,124th among 4,983 insiders by purchase value, well below the average of $1.46 million over about 3.3 transactions. No open market sales reported.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Nautilus Biotechnology, Inc. | $NAUT | Murphy Matthew B. | General Counsel | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 126,305,122 | 9999.99% | 0.13% |
| Sept. 4, 2025 | Nautilus Biotechnology, Inc. | $NAUT | Murphy Matthew B. | General Counsel | P | Common Stock | 20000 | $0.64 | 75,390.0000 | 126,148,469 | 36.11% | 0.02% |
| March 3, 2025 | Nautilus Biotechnology, Inc. | $NAUT | Murphy Matthew B. | General Counsel | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 126,148,469 | 9999.99% | 0.13% |
| March 1, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Murphy Matthew B. | General Counsel | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2023 | Nautilus Biotechnology, Inc. | $NAUT | Murphy Matthew B. | General Counsel | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 0 | 9999.99% | 0.00% |